![Jay Siegel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 35 400 $ al 31/10/2026
Jay Philip Siegel is currently Co-Chairman of the Regenerative Medicine Forum at The National Academies of Science and Chief Biotechnology Officer at Janssen Research & Development LLC.
Former positions include Director at Biotechnology Innovation Organization, Director at Alliance for Regenerative Medicine, Independent Director at MacroGenics, Inc. from 2017 to 2026, and Chief Biotechnology Officer at Johnson & Johnson.
Education includes a doctorate from Stanford University and an undergraduate degree from California Institute of Technology.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
MACROGENICS, INC. 0,02 % | 18/05/2026 | 14.750 ( 0,02 % ) | 35 400 $ | 31/10/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Janssen Research & Development LLC
 Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development medicines and solutions to other medical needs | Corporate Officer/Principal | - |
The National Academies of Science
 The National Academies of Science Miscellaneous Commercial ServicesCommercial Services Provides advice and reports in sciences, engineering and medicine | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
| MACROGENICS, INC. | Director/Miembro de la Junta | 19/05/2026 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Director/Miembro de la Junta | - |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MacroGenics, Inc.
 MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The National Academies of Science
The National Academies of Science Miscellaneous Commercial ServicesCommercial Services Provides advice and reports in sciences, engineering and medicine | Commercial Services |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development medicines and solutions to other medical needs | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
